Marc Better PhD

Dr. Better joined the Kite leadership team in Jan 2013. He brings more than 20 years of experience as a biotechnology professional in biologics CMC; upstream, downstream, analytical and drug product process development; non-GMP and GMP manufacturing; commercial manufacturing support; technology transfer for biologics; contract manufacturing of recombinant proteins; and regulatory interactions. Dr. Better has a proven track record of strong business skills and technical depth. Prior to joining Kite, Dr. Better was Executive Director, Process Science at Boehringer Ingelheim where he led a group of 50 scientists and engineers responsible for process development, technology transfer and overall CMC activities for biotechnology products. Before joining Boehringer Ingelheim, Dr. Better was Executive Director, Process Development at Amgen where he led the development effort for licensure of the monoclonal antibody Vectibix® in the US, Europe, Japan and more than 30 other jurisdictions. Dr. Better joined Amgen through the acquisition of Abgenix in 2006, where he served as Vice President, Process Sciences. Prior to Abgenix, Dr. Better was Vice President, Technical Development at XOMA. Dr. Better received his Ph.D. in Biochemistry from Brandeis University and holds a B.S in Microbiology from Michigan State University. He is an author on more than 35 scientific publications, and inventor on more than 20 issued US patents.